We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10.7B
AUM Growth
+$2.5B
Cap. Flow
+$2B
Cap. Flow %
18.71%
Top 10 Hldgs %
43.17%
Holding
3,695
New
1,259
Increased
473
Reduced
526
Closed
1,295

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$136M
2
LIN icon
Linde
LIN
+$111M
3
VLO icon
Valero Energy
VLO
+$106M
4
PANW icon
Palo Alto Networks
PANW
+$105M
5
LMT icon
Lockheed Martin
LMT
+$104M

Sector Composition

Rank Sector Weight
1 Technology 8.52%
2 Consumer Discretionary 7.25%
3 Industrials 6.98%
4 Financials 6.35%
5 Healthcare 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIH
2101
SAIHEAT Ltd
SAIH
$38.9M
$20K ﹤0.01%
+976
New +$31.3K
PXMD
2102
DELISTED
PaxMedica, Inc. Common Stock
PXMD
$20K ﹤0.01%
+1,528
New +$37.5K
BGDE
2103
Big Digital Energy Inc
BGDE
$31.2M
$19K ﹤0.01%
+526
New +$29.1K
RIGL icon
2104
Rigel Pharmaceuticals
RIGL
$733M
$19K ﹤0.01%
1,485
-558
-27% -$7.54K
SFR
2105
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
$19K ﹤0.01%
52,468
-23,647
-31% -$11.5K
CPUH.WS
2106
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$19K ﹤0.01%
38,540
CGC
2107
Canopy Growth
CGC
$394M
$18K ﹤0.01%
4,681
-98,956
-95% -$1.04M
TLSA icon
2108
Tiziana Life Sciences
TLSA
$124M
$18K ﹤0.01%
+26,494
New +$22.4K
CELL
2109
DELISTED
PhenomeX Inc. Common Stock
CELL
$18K ﹤0.01%
+37,244
New +$30.5K
LTCH
2110
DELISTED
Latch, Inc. Common Stock
LTCH
$18K ﹤0.01%
+13,656
New +$12.8K
GORO icon
2111
Goldgroup Mining Inc.
GORO
$160M
$17K ﹤0.01%
28,202
-115,533
-80% -$102K
REVB icon
2112
Revelation Biosciences
REVB
$4.38M
$17K ﹤0.01%
+3
New +$18.8K
SCLXW icon
2113
Scilex Holding Co Warrant
SCLXW
$2.77M
$17K ﹤0.01%
12,917
TLRY icon
2114
PUT
Tilray
TLRY
$605M
$17K ﹤0.01%
+1,090
New +$23.4K
VZLA
2115
Vizsla Silver
VZLA
$1.24B
$17K ﹤0.01%
+14,226
New +$19.1K
AAC.WS
2116
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$17K ﹤0.01%
21,947
SRGA
2117
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$17K ﹤0.01%
+96,529
New +$92.6K
EEIQ icon
2118
EpicQuest Education Group
EEIQ
$3.85M
$16K ﹤0.01%
+802
New +$19.4K
NIOBW
2119
NioCorp Developments Ltd Warrant
NIOBW
$70.8M
$16K ﹤0.01%
24,975
ONDS icon
2120
Ondas Inc
ONDS
$4.98B
$16K ﹤0.01%
+19,117
New +$18.2K
PHUN icon
2121
Phunware
PHUN
$44.6M
$16K ﹤0.01%
+609
New +$18.6K
VANI icon
2122
Vivani Medical
VANI
$117M
$16K ﹤0.01%
+13,923
New +$17.1K
YSG
2123
Yatsen Holding
YSG
$304M
$16K ﹤0.01%
3,302
+111
+3% +$571
VWE
2124
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$16K ﹤0.01%
+19,381
New +$22.5K
ARDS
2125
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$16K ﹤0.01%
73,723
+56,496
+328% +$13K

Similar funds

HRT Financial's Q2 2023 Portfolio in Review

As of Q2 2023, HRT Financial held 3,695 positions worth $10.7B, up 30% from $8.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

HRT Financial deployed $2B of net new capital in Q2 2023, opening 1,259 new positions and adding to 473 existing holdings. Its largest new stake was Blackstone: 1,401,378 shares worth $130M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $136M trimmed.

  • HRT Financial's largest Q2 2023 buy was Blackstone: 1,401,378 shares worth $130M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $2.08B increase.
  • HRT Financial's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $136M.
  • HRT Financial fully exited Palo Alto Networks in Q2 2023, selling an estimated $105M.
  • HRT Financial's ten largest holdings make up 43% of its $10.7B portfolio in Q2 2023.
  • HRT Financial opened 1,259 new positions and closed 1,295 in Q2 2023.
  • HRT Financial's portfolio value rose 30% quarter-over-quarter to $10.7B.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.